NASDAQ:OPRX OptimizeRx Q4 2025 Earnings Results & Report $8.43 +0.21 (+2.55%) Closing price 04:00 PM EasternExtended Trading$8.38 -0.05 (-0.59%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. OptimizeRx reported Q4 2025 earnings on January 31, 2026. The company reported EPS of $0.51. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2025Report DateJanuary 31, 2026TimeAfter Market Closes OptimizeRx EPS ResultsActual EPS$0.51Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate7 of last 8 quartersOptimizeRx Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsOptimizeRx's Q3 2026 earnings is estimated for Thursday, November 5, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2026 Earnings ReportConference Call ResourcesEarnings HistoryCompany Profile OptimizeRx Q4 2025 Earnings FAQ Did OptimizeRx beat earnings estimates for Q4 2025? OptimizeRx (NASDAQ:OPRX) reported earnings of $0.51 per share for Q4 2025. The report was announced on Saturday, January 31, 2026. When is OptimizeRx's next earnings date? OptimizeRx's next earnings date is estimated for Thursday, November 5, 2026. MarketBeat tracks confirmed and estimated earnings dates for OptimizeRx on the company's earnings history page. OptimizeRx Earnings HeadlinesOptimizeRx (NASDAQ:OPRX) & Certara (NASDAQ:CERT) Head to Head ContrastOctober 12 at 4:45 AM | americanbankingnews.comTeladoc Health (NYSE:TDOC) and OptimizeRx (NASDAQ:OPRX) Head-To-Head ContrastOctober 8, 2026 | americanbankingnews.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 13 at 1:00 AM | Stansberry Research (Ad)OptimizeRx Corp. And The Trade Desk Bring Net New Authenticated HCP Reach To The Trade Desk Through OpenPathSeptember 22, 2026 | marketscreener.comMOptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPathSeptember 22, 2026 | globenewswire.comOptimizeRx: Gross Margin Gains And Improved Long-Term OutlookSeptember 18, 2026 | seekingalpha.comSee More OptimizeRx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like OptimizeRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OptimizeRx and other key companies, straight to your email. Email Address About OptimizeRxOptimizeRx (NASDAQ:OPRX) Corporation is a digital health company that provides technology and communication solutions for the life sciences and healthcare industries. Its platform connects pharmaceutical and biotechnology companies with healthcare providers and patients through digital channels integrated into electronic health records, electronic prescribing systems and other clinical workflows. The company’s solutions support activities such as delivering treatment information, patient savings and affordability offers, medication adherence programs, and other communications intended to help patients access and remain on prescribed therapies. OptimizeRx also provides tools designed to help life sciences companies engage healthcare professionals, support product education and generate insights from healthcare data. Founded in 2006, OptimizeRx has primarily served the U.S. healthcare market, working with pharmaceutical manufacturers, biotechnology companies, healthcare providers and technology partners. The company is headquartered in Michigan and has historically been led by co-founder and Chief Executive Officer William J. Febbo.View OptimizeRx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?A Silent Winner: Texas Instruments Anchors the AI SupercycleDelta's Guidance Cut Could Spell Trouble for the Airline Industry5 Retail Picks to Watch as the Holiday Shopping Season Nears Upcoming Earnings Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026)Fastenal (10/14/2026)ASML (10/14/2026)Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
